期刊文献+

基于FAERS的阿伐曲泊帕不良事件信号挖掘与分析

Signal mining and analysis for adverse events of avatrombopag based on FAERS
下载PDF
导出
摘要 目的 基于真实世界数据挖掘血小板减少症治疗药物阿伐曲泊帕的药物不良事件(adverse drug events, ADE)信号,为其临床安全应用提供参考。方法 通过OpenVigil2.1药物警戒平台获取美国食品药品监督管理局不良事件报告系统中2018年5月至2023年3月阿伐曲泊帕的ADE数据,利用《国际医学用语词典》(26.0版)中ADE术语集的首选系统器官分类(system organ class, SOC)和首选术语(preferred term, PT)对ADE信号进行分类和描述,并采用报告比值比(reporting odds ratio, ROR)法和英国药品和保健品管理局综合标准法对ADE数据进行信号检测。结果 共获取到阿伐曲泊帕相关ADE报告1 879份,累及24个SOC,在PT层级检测到阳性ADE信号28个,其中信号最强的是肾静脉血栓形成、门静脉血栓形成和移植物抗宿主病,报告数最多的是头痛、疲劳和乏力,新发现了8个ADE信号,分别是季节性过敏、背部疾病、肌肉骨骼不适、肠胃气胀、睡眠过度、斑状皮疹、情绪障碍和流涕。结论 临床应用阿伐曲泊帕时不仅要关注其血栓形成风险,还应密切关注季节性过敏、背部疾病、肌肉骨骼不适、肠胃气胀、睡眠过度、斑状皮疹、情绪障碍和流涕等说明书尚未记载的ADE信号。 Objective To mine the adverse drug events(ADE)signal of avatrombopag,an effective drug for thrombocytopenia treatment,based on real world data in order to provide reference for its clinical safety application.Methods The OpenVigil2.1 pharmacovigilance platform was used to obtain the ADE report data of avatrombopag from May 2018 to March 2023 in the database of FDA adverse event reporting system(FAERS).The ADE signals were classified and described by the system organ class(SOC)and preferred term(PT)of the ADE terminology set in the Medical Dictionary for Regulatory Activities(MedDRA),and reporting odds ratio(ROR)and UK Medicines and Healthcare Products Regulatory Agency(MHRA)comprehensive standard were used to detect the positive ADE signals.Results A total of 1879 ADE reports related to avatrombopag were obtained,24 SOCs were involved,and 28 positive ADE signals were detected at PT level.Among these signals,the strongest ones were renal vein thrombosis,portal vein thrombosis and graft versus host disease,while the reports accounting for the largest numbers were headache,fatigue and asthenia.There were 8 ADE signals discovered newly,that is,seasonal allergy,back disorder,musculoskeletal discomfort,flatulence,hypersomnia,rash macular,emotional disorder,and rhinorrhoea.Conclusion For clinical use of avatrombopag,clinicians should not only concern the risk of thrombosis,but also pay close attention to ADE signals such as seasonal allergy,back disorder,musculoskeletal discomfort,flatulence,hypersomnia,rash macular,emotional disorder,and rhinorrhoea that are not documented in the instructions.
作者 熊瑞 王瑾 杨振 罗艳梅 张宏 仝永涛 来小丹 XIONG Rui;WANG Jin;YANG Zhen;LUO Yanmei;ZHANG Hong;TONG Yongtao;LAI Xiaodan(Department of Pharmacy,No.958 Hospital of PLA,Chongqing,400020;Department of Pharmacy,No.956 Hospital of PLA,Nyingchi,Xizang Autonomous Region,860000,China)
出处 《陆军军医大学学报》 CAS CSCD 北大核心 2024年第4期369-376,共8页 Journal of Army Medical University
基金 重庆市科卫联合项目(2022MSXM187)。
关键词 阿伐曲泊帕 血小板减少症 不良事件 FDA不良事件报告系统 数据挖掘 avatrombopag thrombocytopenia adverse events FDA adverse event reporting system data mining
  • 相关文献

参考文献6

二级参考文献38

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部